Despite a 6% sequential operating expense decline in Q3, we expect a sequential increase in Q4 driven by the AAO trade show expenses, increased marketing expense, initial international hiring, and stock-based compensation.

Nov 5, 2025 / receipt

Despite a 6% sequential operating expense decline in Q3, we expect a sequential increase in Q4 driven by the AAO trade show expenses, increased marketing expense, initial international hiring, and stock-based compensation.

Nov 5, 2025 / receipt, needs a key / Shally Toonan, CFO | earnings call 2025-11-05 | transcript e61d69f3-e9cd-40fc-afdc-44de010a2e8b | chars 8989-9211 | segment 9

SG&A expenses in the third quarter of 2024 were $25.6 million, representing an increase of $6.5 million, or 34%, versus $19.1 million in the year-ago quarter. This year-over-year change was due primarily to an increase in personnel costs, travel for sales and support teams, and higher stock-based compensation expense.

Nov 9, 2024 / receipt, needs a key / Shelley Tunin, CFO | earnings call 2024-11-09 | transcript 19d8542f-e402-4a7c-bd1e-550461a2cf2b | chars 9032-9351 | segment 9

SG&A expenses in the third quarter of 2023 were $19.1 million, up 28%, versus $14.9 million in the year-ago quarter, reflecting SOX implementation and consulting costs and increased expenses in sales and clinical personnel costs and travel.

Nov 9, 2023 / receipt, needs a key / Shelley Tunant, CFO | earnings call 2023-11-09 | transcript f6187686-662b-44f2-8c18-6ecbf7d711b4 | chars 9235-9475 | segment 9

SG&A expenses in the second quarter of 2023 were $18.2 million, up 27%, versus $14.4 million in the year-ago quarter, reflecting increased expenses in sales and marketing, personnel costs, and travel.

Aug 7, 2023 / receipt, needs a key / Shelley Toonan, CFO | earnings call 2023-08-07 | transcript cf3df27a-1c41-482b-8140-70f008cd8441 | chars 4437-4637 | segment 4

SD&A expenses in the first quarter of 2023 were $16.3 million, up 19% versus $13.6 million in the year-ago quarter, reflecting increased expenses in sales and marketing personnel costs and travel and increased non-cash stock-based compensation expense in sales, marketing, and G&A.

May 9, 2023 / receipt, needs a key / Shelley Toonan, CFO | earnings call 2023-05-09 | transcript e42a2c40-4b2a-4227-845a-cafea00c219b | chars 4271-4552 | segment 4

On a sequential basis, SG&A expenses rose 5% from $14.9 million in the third quarter of 2022, due primarily to a major professional meeting, increased travel, and increased incentive compensation on higher revenues.

Mar 6, 2023 / receipt, needs a key / Chellie Tunan, CFO | earnings call 2023-03-06 | transcript ba0c1bd4-227e-4502-bc16-75e0ab684fe1 | chars 5478-5693 | segment 5

SG&A expenses rose 79% to $58.7 million, due primarily to investments made to expand the spies and scope of our commercial organization, resumption of in-person, ophthalmic meetings, and increased travel.

Mar 6, 2023 / receipt, needs a key / Chellie Tunan, CFO | earnings call 2023-03-06 | transcript ba0c1bd4-227e-4502-bc16-75e0ab684fe1 | chars 6960-7164 | segment 6

The sequential increase of 5.6% from the first quarter of this year was related primarily to increased travel and headcount in sales and marketing.

Aug 8, 2022 / receipt, needs a key / Shelley Tunin, CFO | earnings call 2022-08-08 | transcript 8b4b8ddc-0912-4396-879c-71110cd78c15 | chars 12273-12420 | segment 12

Payroll and Equity Manager | {"ats": "smartrecruiters", "city": "Aliso Viejo", "state": "CA", "job_id": "743999804280597", "remote": false, "category": "finance_ops", "function": "finance", "location"

company_statement / Feb 8, 2022 / receipt